Yao-Chen Wang
Chung Shan Medical University Hospital(TW)Chung Shan Medical University(TW)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, Lung Cancer Treatments and Mutations, RNA modifications and cancer, PI3K/AKT/mTOR signaling in cancer, MicroRNA in disease regulation
Most-Cited Works
- → Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2(2015)136 cited
- → IL-10 Promotes Tumor Aggressiveness via Upregulation of CIP2A Transcription in Lung Adenocarcinoma(2013)74 cited
- → A Polymorphic −844T/C in FasL Promoter Predicts Survival and Relapse in Non–Small Cell Lung Cancer(2011)58 cited
- → Up-Regulation of FOXM1 by E6 Oncoprotein through the MZF1/NKX2-1 Axis Is Required for Human Papillomavirus–Associated Tumorigenesis(2014)57 cited
- → PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression(2017)49 cited
- → Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression(2013)44 cited
- → PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness(2016)35 cited
- → A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop(2018)34 cited
- → Dioscin overcome TKI resistance in EGFR-mutated lung adenocarcinoma cells via down-regulation of tyrosine phosphatase SHP2 expression(2018)33 cited
- → MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2(2018)28 cited